Change search
ReferencesLink to record
Permanent link

Direct link
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Show others and affiliations
2005 (English)In: J Am Coll Cardiol, ISSN 0735-1097, Vol. 45, no 5, 705-11 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 45, no 5, 705-11 p.
Keyword [en]
Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin II Type 1 Receptor Blockers/*therapeutic use, Antihypertensive Agents/*therapeutic use, Atenolol/therapeutic use, Atrial Fibrillation/*mortality, Cardiovascular Diseases/*mortality, Cause of Death, Double-Blind Method, Electrocardiography/drug effects, Female, Humans, Hypertension/*drug therapy/*mortality, Hypertrophy; Left Ventricular/*drug therapy/*mortality, Losartan/*therapeutic use, Male, Middle Aged, Prospective Studies, Risk Factors, Survival Analysis
URN: urn:nbn:se:umu:diva-6292DOI: doi:10.1016/j.jacc.2004.06.080PubMedID: 15734614OAI: diva2:145961
Available from: 2007-12-08 Created: 2007-12-08 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 19 hits
ReferencesLink to record
Permanent link

Direct link